Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Access to experimental drugs for terminally ill patients.

× No keyword cloud information.

6 in total

1. Characterizing expanded access and compassionate use programs for experimental drugs.

Authors: Jennifer E Miller; Joseph S Ross; Kenneth I Moch; Arthur L Caplan
Journal: BMC Res Notes Date: 2017-07-28

Review 2. Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.

Authors: Elena Fountzilas; Rabih Said; Apostolia M Tsimberidou
Journal: Expert Opin Investig Drugs Date: 2018-01-22 Impact factor: 6.206

3. What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.

Authors: Eline M Bunnik; Nikkie Aarts
Journal: BMC Med Ethics Date: 2019-11-09 Impact factor: 2.652

4. Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.

Authors: Jeremiah Stout; Cambray Smith; Jan Buckner; Alex A Adjei; Mark Wentworth; Jon C Tilburt; Zubin Master
Journal: PLoS One Date: 2021-12-17 Impact factor: 3.240

5. Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

Authors: Tim K Mackey; Virginia J Schoenfeld
Journal: BMC Med Date: 2016-02-02 Impact factor: 8.775

6. An analysis of common ethical justifications for compassionate use programs for experimental drugs.

Authors: Kasper Raus
Journal: BMC Med Ethics Date: 2016-10-18 Impact factor: 2.652

6 in total